Serialisation — looking for value-added opportunities

15 May 2018

Recipharm's Staffan Widengren, Director Corporate Projects, discusses why CMOs should be focusing on the value-added opportunities presented by serialisation.

The European Falsified Medicines Directive (EU FMD) is just months from its enforcement date. Yet, the industry still has a long way to go if compliance is to be achieved.

Serialisation — looking for value-added opportunities

TraceLink’s Global Drug Supply Safety and Traceability Report, which includes results from a survey of over 600 respondents, found that 88% of CMOs are concerned that equipment shortages will affect their ability, or their customers’ ability, to comply with the regulations. The survey also revealed that 94% of CMOs felt ‘somewhat’ or ‘very prepared’ for serialisation, yet less than half (42%) had not begun preparing.

Staffan Widengren, Director Corporate Projects at Recipharm, discusses the results of the survey and why CMOs should be focusing on the value-added opportunities presented by serialisation.

Do you think CMOs are right to be concerned about potential equipment shortages in the lead up to the EU FMD?

It’s a legitimate concern, vendors are dealing with significant order volumes and having to prioritize larger customers — lead times from machine vendors have increased significantly from order to delivery in the last year. For a standard machine the lead time today is likely to be over 8 months — Recipharm was working to a timescale of less than 6 months when it started its serialisation program. For businesses yet to select a vendor, they will have to opt for standard machines without customization.

78% of CMOs were already working on value-added projects — why do you think CMOs in the EU are so focused on added-value at this stage?

As the investments required of companies working towards serialisation are so high for a compliance requirement, CMOs are looking for areas where they could gain and add value both internally and for their customers. Developing means of interpreting and utilizing the big data being generated to make improvements in efficiency is a top priority for many.

Why do you think CMOs felt prepared for serialisation despite not having begun any actual preparations?

There’s little doubt that CMOs are aware of the requirement and have begun planning in some way. However, as the serialisation challenge is completely new, there has been some naivety from many businesses and many have failed to appreciate the preparation time required, the lengthening lead times for machines and software from vendors, the complexity of onboarding customers and the difficulty involved in securing approval from top management concerning capex and costs.

Staffan Widengren will be presenting at FutureLink Munich, 5-7 June 2018, on the ‘Final countdown: focus areas for a CDMO before February 2019'.

Read More

Related news

Building contingency plans for an ambiguous post-Brexit market

Building contingency plans for an ambiguous post-Brexit market

31 Jul 2018

One company's positive approach to Brexit preparations, despite the lack of definition.

Read more 
Post-Brexit medicines - stuck in the UK?

Post-Brexit medicines - stuck in the UK?

30 Jul 2018

The EMA needs to provide more action and guidance to help UK pharmaceutical manufacturers, says Thomas Beck, senior vice president, quality management, Recipharm.

Read more 
Pharmacovigilance post-Brexit - simpler than previously thought?

Pharmacovigilance post-Brexit - simpler than previously thought?

24 Jul 2018

To meet new PV regulations, the industry has to face a "multitude of unknowns and an ever-moving target".

Read more 
South Korea's finished drug market growth driven by generics

South Korea's finished drug market growth driven by generics

16 Jul 2018

FDF launches at CPhI Korea as country set to become regional hub.

Read more 
Bosch to sell its packaging business

Bosch to sell its packaging business

4 Jul 2018

Packaging technology is not a core Bosch business.

Read more 
Ingredients to improve bioprocess manufacturing efficiency

Ingredients to improve bioprocess manufacturing efficiency

27 Jun 2018

Experts warn bio industry needs to do more to create a sustainable pipeline of talent.

Read more 
Internationalisation and regulatory reform driving growth and investment at CPhI China

Internationalisation and regulatory reform driving growth and investment at CPhI China

22 May 2018

2018 event prepares for surge in international attendees as MAH nears national rollout.

Read more 
Investing in blistering capabilities to boost flexibility

Investing in blistering capabilities to boost flexibility

16 May 2018

Postponement printing is presenting interesting benefits for the pharmaceutical supply chain.

Read more 
Industry’s largest survey on serialization readiness throws up disparity

Industry’s largest survey on serialization readiness throws up disparity

30 Apr 2018

Global Drug Supply, Safety and Traceability Report reveals disparity in industry’s readiness to comply with track and trace regulations in the US and EU.

Read more 
Omega-3s from fish oil supplements no better than placebo for dry eye

Omega-3s from fish oil supplements no better than placebo for dry eye

15 Apr 2018

NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.

Read more